Cinterion Honored as Part of 2012 Connected World Gold Value Chain Award for Enabling mHealth Solution

Cinterion Honored as Part of 2012 Connected World Gold Value Chain Award for Enabling mHealth Solution

TZ Medical Aera CT device with embedded Cinterion M2M technology takes top honors in healthcare category.

Cinterion, Gemalto’s (Euronext NL 0000400653 GTO) machine-to-machine (M2M) business segment and the global leader in cellular M2M communication technology, and TZ Medical, a leading manufacturer of medical products, today announced jointly winning Connected World Magazine’s prestigious Gold Value Chain Award for Aera CT™, a lightweight and cost effective mHealth heart arrhythmia monitoring device. The Value Chain Awards honor the most successful corporate adopters of M2M technology and the solution providers that make their success possible.

TZ Medical’s Aera CTTZ Medical’s Aera CT device improves the ability to detect heart arrhythmias during normal day-to-day activities, and over long periods of time. Designed for ease-of-use and comfort for patients, the device uses a Cinterion M2M module to enable the Aera CT device to communicate data via cellular networks and the Internet. TZ Medical’s solution provides patients and their physicians with 24/7 monitoring and improved detection and visibility of irregular heart rhythms. Authorized caregivers can securely log-on and view patient data from anywhere in the world and with total privacy protection, to determine effective treatment approaches.

The 2012 winners represent successful implementations in home health, education, emergency response, tracking, and even the prevention of distracted driving. This is a great illustration as to how M2M technology and connected devices can be relied upon to not only make our lives more convenient and efficient, but much safer and responsible,” says Peggy Smedley, editorial director, Connected World. “Congratulations to all of the individuals and companies honored.”

Norbert Muhrer, Senior Vice President of Cinterion M2M at Gemalto said:

“PricewaterhouseCoopers estimates that wireless remote diagnostic services will generate $3.4 billion in revenues worldwide by 2017, making up 15 percent of the global mHealth market1.”

“The award-winning Aera CT solution demonstrates how secure and reliable Cinterion M2M technology can contribute to drive efficiency gains and growth in the mHealth services sector.”

1MobiHealthNews, February 15, 2012, Brian Dolan, “Europe to be bigger market for mHealth than North America

About Cinterion, a Gemalto Company
Cinterion, the Machine-to-Machine (M2M) segment of Gemalto (Euronext NL 0000400653 GTO), is the industry pioneer for wireless M2M communication and market leader for more than 15 years. Cinterion enables businesses to succeed in a complex M2M ecosystem by offering expertise, security, simplicity and partnership. Cinterion’s award-winning products and services connect people, machines, equipment and vehicles over wireless networks, helping enterprises simplify operations, increase efficiency and establish new business models. Equipment makers, integrators, MNOs, and end-users rely on Cinterion for leading-edge wireless M2M communication modules, Machine Identification Modules (MIMs), MIM personalization capabilities plus a trusted and secure, cloud-based Service Delivery Platform for any M2M application. Cinterion powers cellular communications for: telematics and automotive applications, tracking and tracing, industrial mobile computing, metering and smart grid, payment systems, healthcare, security systems, routers and gateways, remote maintenance and control and more.

Related posts